| View |
|
DRP-6103
|
Lisinopril (As Dihydrate)
|
Holpril-20
|
20 mg
|
Tablet
|
-
|
Holden Medical Laboratories Pvt. Ltd.
|
India
|
-
|
17 November 2021
|
08 April 2025
|
| View |
|
DR-XY37855
|
Nystatin
|
Fungystine
|
100,000 units/mL
|
Suspension
|
-
|
Swisspharma Research Laboratories, Inc.
|
Philippines
|
-
|
17 November 2021
|
27 April 2025
|
| View |
|
DRP-3210-04
|
Cefuroxime (As Axetil)
|
Trixime
|
250mg/5mL
|
Powder for suspension
|
Antibacterial (Cephalosporin)
|
Biopharma Ltd.
|
Bangladesh
|
Automatic Renewal
|
08 December 2022
|
08 September 2027
|
| View |
|
DR-XY38072
|
Ketotifen Fumarate
|
Privent
|
0.05% w/v
|
Ophthalmic Solution
|
-
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
10 November 2021
|
07 June 2025
|
| View |
|
DRHR-1294
|
Ascorbic Acid
|
Ceefadin SA
|
500 mg Capsule (equivalent to 568.18 mg Sodium Ascorbate
|
Capsule
|
-
|
Am-Europharma Corporation
|
Philippines
|
-
|
15 November 2021
|
26 March 2025
|
| View |
|
DRP-1079
|
Enalapril Maleate
|
Scheepril
|
5 mg
|
Tablet
|
Angiotensin-Converting Enzyme (ACE) Inhibitor
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
Renewal (Revalidation)
|
17 November 2021
|
06 July 2027
|
| View |
|
DRP-10763
|
Dutasteride + Tamsulosin hydrochloride
|
Dutass
|
500 mcg/400 mcg
|
Capsule
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
16 November 2021
|
16 November 2026
|
| View |
|
DRP-6348-01
|
Lansoprazole
|
Lansomedix
|
30 mg
|
Delayed-Release Capsule
|
-
|
Scott-Edil Pharmacia Limited
|
India
|
-
|
10 November 2021
|
15 May 2025
|
| View |
|
DRP-6349-01
|
Losartan Potassium + Amlodipine (as besilate)
|
Dailyzar
|
50 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Calcium Channel
Blocker
|
Micro Labs Ltd.
|
India
|
Automatic Renewal
|
19 November 2021
|
25 May 2025
|
| View |
|
DRP-10697
|
Piperacillin+ Tazobactam
|
Pipetasaph-4.5
|
4 g / 500 mg
|
Powder for Injection for I.V. Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Kilitch Drugs (India) Ltd.
|
India
|
-
|
10 November 2021
|
10 November 2026
|
| View |
|
DRHR-1423
|
Calamine + Zinc Oxide
|
None
|
8g/8g per 100mL
|
Lotion
|
-
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
-
|
19 November 2021
|
27 April 2025
|
| View |
|
DRP-2755
|
Cefoxitin (As Sodium)
|
Cefoxivit
|
1 g
|
Powder for Injection (I.M./I.V.)
|
-
|
Vitrofarma S.A.
|
Colombia
|
-
|
19 November 2021
|
31 August 2025
|
| View |
|
DRP-10286
|
Ascorbic Acid
|
Rexvita-C
|
500 mg
|
Tablet
|
-
|
Jiangxi Xier Kangtai Pharmaceutical Co., Ltd.
|
China
|
-
|
16 November 2021
|
16 November 2026
|
| View |
|
DR-XY38717
|
Ceftazidime (As Pentahydrat)
|
Sefta
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
-
|
22 November 2021
|
03 November 2025
|
| View |
|
DRP-8514-03
|
Clopidogrel (As Bisulfate)
|
None
|
75 mg
|
Film coated tablet
|
Platelet Aggregation inhibitor
|
Mepro Pharmaceutical Private Limited
|
India
|
Automatic Renewal
|
01 July 2022
|
22 November 2027
|
| View |
|
DRP-8527-01
|
Amlodipine (As Besilate) + Losartan Potassium
|
Arbloc CCB
|
5 mg/ 100 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker/Angiotensin II Antagonist
|
Lloyd laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 March 2023
|
20 September 2028
|
| View |
|
DRP-8848-01
|
Risperidone
|
Risdin
|
1mg/mL
|
Oral Solution
|
Antipsychotic
|
Chanelle Medical
|
Ireland
|
Renewal
|
19 June 2024
|
15 May 2030
|
| View |
|
DRP-2122-03
|
Guaifenesin + Salbutamol (as sulfate)
|
Prometasol Plus
|
100mg/2mg
|
Capsule
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
31 May 2022
|
12 July 2027
|
| View |
|
DRP-2122-02
|
Guaifenesin + Salbutamol (as sulfate)
|
Nasamed
|
100 mg/2 mg
|
Capsule
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
26 May 2022
|
12 July 2027
|
| View |
|
DRP-2122-05
|
Guaifenesin + Salbutamol (as sulfate)
|
Medusin
|
100mg/2mg
|
Capsule
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
09 June 2022
|
12 July 2027
|